T70335
Cangrelor free acid
TargetMol
DESCRIPTION
Cangrelor is a P2Y12 inhibitor, and was approved in June 2015 as an antiplatelet drug for intravenous application. Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. It does not require metabolic conversion to an active metabolite. This allows cangrelor’s immediate effect after infusion, and the therapeutic effects can be maintained with continuous infusion.
DETAILS
- Cas: 163706-06-7
- Purity: 98%
- Smiles: N(CCSC)C1=C2C(N(C=N2)[C@@H]3O[C@H](COP(OP(C(P(=O)(O)O)(Cl)Cl)(=O)O)(=O)O)[C@@H](O)[C@H]3O)=NC(SCCC(F)(F)F)=N1
- Category: Compound
- Molecular Weight: 776.36
- Molecular Formula: C17H25Cl2F3N5O12P3S2
Lead Time: Please Inquire
Sign in to view pricingEquivalent Items
| ... Loading